HSPPC-96
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for HSPPC-96, covering 2012-09-07 to 2024-02-28. Get the full timeline:
Most recent: Clinical Trial Update: Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM) [Phase 2]